Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Stemtech (STEK) Research & Development (2023)

Stemtech's Research & Development history spans 1 years, with the latest figure at -$177.0 for Q4 2023.

  • For Q4 2023, Research & Development changed N/A year-over-year to -$177.0; the TTM value through Sep 2024 reached -$177.0, down 101.27%, while the annual FY2023 figure was $13800.0, N/A changed from the prior year.
  • Research & Development for Q4 2023 was -$177.0 at Stemtech, down from $177.0 in the prior quarter.
  • Across five years, Research & Development topped out at $13800.0 in Q1 2023 and bottomed at -$177.0 in Q4 2023.